# IN8BIO, Inc.: filings

INAB · Nasdaq · CIK 1740279 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/inab.md) · [Financials](/companies/inab/financials.md) · [Filings](/companies/inab/filings.md) · [Insiders](/companies/inab/insiders.md)

## Reports and events: 118 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 162, 8-K 75, 3 17, 10-Q 16, CORRESP 15, 424B5 7, EFFECT 7, S-8 7, S-8 POS 7, SCHEDULE 13G/A 7, UPLOAD 7, 4/A 6, S-1/A 6, 10-K 5, DEF 14A 5, DEFA14A 5, S-3 5, SCHEDULE 13G 5, ARS 4, D 4, SC 13G 4, 424B3 3, SC 13G/A 3, SCHEDULE 13D/A 3, 424B4 2, D/A 2, DRS 2, S-1 2, SC 13D/A 2, SEC STAFF LETTER 2, 10-K/A 1, 8-A12B 1, 8-K/A 1, CERT 1, DEFR14A 1, DRS/A 1, DRSLTR 1, POS EX 1, PRE 14A 1, S-3/A 1, SC 13D 1, SCHEDULE 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-06 | 16:11 ET | [10-Q](/filings/0001193125-26-338012.md) | Quarterly report, period 2026-06-30 | 0001193125-26-338012 |
| 2026-08-06 | 16:05 ET | [8-K](/filings/0001193125-26-337944.md) | 2.02 Results of operations | 0001193125-26-337944 |
| 2026-06-01 | 06:56 ET | [8-K](/filings/0001193125-26-249684.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001193125-26-249684 |
| 2026-05-29 | 17:41 ET | [SCHEDULE 13D/A](/filings/0001682638-26-000008.md) | Ownership report, active investor, amended | 0001682638-26-000008 |
| 2026-05-07 | 16:32 ET | [10-Q](/filings/0001193125-26-212135.md) | Quarterly report, period 2026-03-31 | 0001193125-26-212135 |
| 2026-05-07 | 16:31 ET | [8-K](/filings/0001193125-26-212128.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-26-212128 |
| 2026-03-26 | 16:05 ET | [DEF 14A](/filings/0001193125-26-126208.md) | Proxy statement, period 2026-05-07 | 0001193125-26-126208 |
| 2026-03-12 | 16:15 ET | [10-K](/filings/0001193125-26-104181.md) | Annual report, period 2025-12-31 | 0001193125-26-104181 |
| 2026-03-12 | 16:10 ET | [8-K](/filings/0001193125-26-104144.md) | 2.02 Results of operations | 0001193125-26-104144 |
| 2026-02-27 | 16:05 ET | [8-K](/filings/0001193125-26-082539.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-082539 |
| 2026-02-09 | 08:31 ET | [8-K](/filings/0001193125-26-041975.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-041975 |
| 2026-01-02 | 19:10 ET | [SCHEDULE 13D](/filings/0001682638-26-000002.md) | Ownership report, active investor | 0001682638-26-000002 |
| 2025-12-29 | 16:00 ET | [SCHEDULE 13D/A](/filings/0001714576-25-000003.md) | Ownership report, active investor, amended | 0001714576-25-000003 |
| 2025-12-19 | 17:22 ET | [8-K](/filings/0001193125-25-327097.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001193125-25-327097 |
| 2025-11-24 | 08:00 ET | [8-K](/filings/0001193125-25-292057.md) | 8.01 Other events | 0001193125-25-292057 |
| 2025-11-06 | 16:03 ET | [10-Q](/filings/0001193125-25-269447.md) | Quarterly report, period 2025-09-30 | 0001193125-25-269447 |
| 2025-11-06 | 16:01 ET | [8-K](/filings/0001193125-25-269442.md) | 2.02 Results of operations | 0001193125-25-269442 |
| 2025-10-27 | 08:01 ET | [8-K](/filings/0001193125-25-250756.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-250756 |
| 2025-08-07 | 16:11 ET | [10-Q](/filings/0000950170-25-105028.md) | Quarterly report, period 2025-06-30 | 0000950170-25-105028 |
| 2025-08-07 | 16:06 ET | [8-K](/filings/0000950170-25-104986.md) | 2.02 Results of operations | 0000950170-25-104986 |
| 2025-06-30 | 08:30 ET | [8-K](/filings/0001193125-25-152037.md) | 8.01 Other events | 0001193125-25-152037 |
| 2025-06-04 | 08:00 ET | [8-K](/filings/0001193125-25-134487.md) | 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001193125-25-134487 |
| 2025-06-02 | 07:36 ET | [8-K](/filings/0001193125-25-132783.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-132783 |
| 2025-05-09 | 16:15 ET | [8-K](/filings/0001193125-25-116901.md) | 5.07 Shareholder vote results | 0001193125-25-116901 |
| 2025-05-08 | 17:53 ET | [SCHEDULE 13D/A](/filings/0001104659-25-046280.md) | Ownership report, active investor, amended | 0001104659-25-046280 |
| 2025-05-07 | 16:21 ET | [10-K/A](/filings/0001193125-25-114915.md) | Annual report, amended, period 2024-12-31 | 0001193125-25-114915 |
| 2025-05-07 | 16:03 ET | [10-Q](/filings/0000950170-25-065609.md) | Quarterly report, period 2025-03-31 | 0000950170-25-065609 |
| 2025-05-07 | 16:01 ET | [8-K](/filings/0000950170-25-065603.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-065603 |
| 2025-04-28 | 08:56 ET | [8-K](/filings/0001193125-25-098599.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-098599 |
| 2025-04-28 | 08:56 ET | [8-K](/filings/0001193125-25-098597.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001193125-25-098597 |
| 2025-03-17 | 16:05 ET | [DEF 14A](/filings/0001193125-25-055610.md) | Proxy statement, period 2025-05-08 | 0001193125-25-055610 |
| 2025-03-13 | 16:10 ET | [10-K](/filings/0000950170-25-038738.md) | Annual report, period 2024-12-31 | 0000950170-25-038738 |
| 2025-03-13 | 16:08 ET | [8-K](/filings/0000950170-25-038728.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-038728 |
| 2025-03-05 | 16:35 ET | [8-K](/filings/0001193125-25-047244.md) | 5.02 Departure or appointment of officers or directors | 0001193125-25-047244 |
| 2025-03-03 | 09:29 ET | [8-K](/filings/0001193125-25-043564.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-043564 |
| 2025-02-11 | 08:11 ET | [8-K](/filings/0001193125-25-024005.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-024005 |
| 2025-02-07 | 16:02 ET | [8-K](/filings/0001193125-25-022711.md) | 3.01 Delisting notice; 5.08 Item not in the standard list | 0001193125-25-022711 |
| 2024-12-10 | 07:15 ET | [8-K](/filings/0001193125-24-273953.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-273953 |
| 2024-11-25 | 07:09 ET | [8-K](/filings/0001193125-24-264714.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-264714 |
| 2024-11-12 | 16:33 ET | [10-Q](/filings/0000950170-24-125537.md) | Quarterly report, period 2024-09-30 | 0000950170-24-125537 |
| 2024-11-12 | 16:30 ET | [8-K](/filings/0000950170-24-125526.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-125526 |
| 2024-10-11 | 18:01 ET | [SC 13D/A](/filings/0001104659-24-108134.md) | Ownership report, active investor, amended | 0001104659-24-108134 |
| 2024-10-01 | 16:59 ET | [8-K](/filings/0001193125-24-230283.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits | 0001193125-24-230283 |
| 2024-09-11 | 16:01 ET | [8-K](/filings/0001193125-24-217229.md) | 5.02 Departure or appointment of officers or directors | 0001193125-24-217229 |
| 2024-09-06 | 16:05 ET | [8-K](/filings/0001193125-24-215154.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-215154 |
| 2024-09-04 | 16:18 ET | [8-K](/filings/0001193125-24-213132.md) | 2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-213132 |
| 2024-08-12 | 08:30 ET | [8-K](/filings/0001193125-24-198411.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-198411 |
| 2024-08-08 | 16:10 ET | [10-Q](/filings/0000950170-24-093943.md) | Quarterly report, period 2024-06-30 | 0000950170-24-093943 |
| 2024-08-08 | 16:08 ET | [8-K](/filings/0000950170-24-093932.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-093932 |
| 2024-06-13 | 16:07 ET | [8-K](/filings/0001193125-24-160703.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-160703 |

Page 1 of 3. [Older](/companies/inab/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.